Pediatric and Adolescent Osteosarcoma provides a review of the nature of osteosarcoma and the conflict that accompanied the introduction of adjuvant therapy for osteosarcoma culminating in accepted and prevailing methods of current therapy. It outlines concepts in epidemiology and etiology, and provides chapters on pathology and radiologic characteristics of osteosarcoma, surgical therapy tailored specifically for treatment of primary tumors in pediatric/adolescent age groups, treatment of pulmonary and extra pulmonary metastases and complications, as well as the role of radiation therapy. The volume concludes with a review of differences and similarities in the management of osteosarcoma in adults as compared to pediatrics / adolescents and new laboratory and animal investigations currently in progress to develop effective diagnostic and therapeutic approaches to improve the outcome.
In essence the scope and intensive coverage of the book provides a historical perspective of the advances made over the past 30 years and emerging concepts and prospects for new diagnostic and therapeutic approaches. This is based upon past experiences and new discoveries. It also provides a unique opportunity for pediatric and adult medical oncologists, physicians in training, orthopedic surgeons, pathologists, radiologists, radiotherapists, oncology nurses and allied professionals involved in the care of pediatric/adolescent patients with osteosarcoma to become acquainted with prevailing methods of treatment and new and evolving concepts and developments.
"Osteosarcoma is the most common primary bone malignancy. Remarkable advances have occurred in the management of this cancer over the last two decades. In this text experts in the field discuss the most pertinent biologic and clinical issues relevant to the disease."
Steven T. Rosen, M.D.Series Editor
Cancer Treatment and Research For other titles published in this series, go to www.springer.com/series/5808 Pediatric and Adolescent Osteosarcoma Edited by Norman Jaffe MD, DSc, Dip Paed Professor Emeritus, Children’s Cancer Hospital, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit #87, Houston, TX 77030-4009, USA Øyvind S. Bruland MD, PhD Professor of Clinical Oncology, Faculty of Medicine, University of Oslo, The Norwegian Radium Hospital, N-0310 Oslo, Norway Stefan S. Bielack Studienleiter, Cooperative Osteosarkomstudiengruppe COSS, Ärztlicher Direktor, Pädiatrie 5 (Onkologie, Hämatologie, Immunologie), Klinikum Stuttgart, Zentrum für Kinder- und Jugendmedizin – Olgahospital, Bismarckstr. 8, D-70176 Stuttgart, Germany Editors Norman Jaffe MD, DSc, Dip Paed Professor Emeritus Children’s Cancer Hospital University of Texas M.D. Anderson Cancer Center 1515 Holcombe Blvd., Unit #87 Houston, TX 77030-4009 USA
[email protected] Stefan S. Bielack Studienleiter, Cooperative Osteosarkomstudiengruppe COSS Ärztlicher Direktor, Pädiatrie 5 (Onkologie, Hämatologie, Immunologie) Klinikum Stuttgart, Zentrum für Kinder- und Jugendmedizin – Olgahospital Bismarckstr. 8, D-70176 Stuttgart Germany
[email protected] Øyvind S. Bruland MD, PhD Professor of Clinical Oncology Faculty of Medicine University of Oslo The Norwegian Radium Hospital N-0310 Oslo, Norway
[email protected] ISBN 978-1-4419-0283-2 e-ISBN 978-1-4419-0284-9 DOI 10.1007/978-1-4419-02